Effects of zoledronic acid on healing of mandibular fractures: An experimental study in rabbits

Journal of Oral and Maxillofacial Surgery

Volumn 69, Issue 6, 2011, Pages 1726-1735

  Tatli, Ufuk ^a   Üstün, Yakup ^b   Kürkçü, Mehmet ^a   Erdoǧan, Özgür ^a   Gürbüz, Cihan Cem ^a   Özgür, Hülya ^a   Polat, Sait ^a  

^a CUKUROVA UNIVERSITY   (Turkey)

^b Oral and Maxillofacial Surgery   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

SODIUM CHLORIDE; ZOLEDRONIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOMECHANICS; BONE RADIOGRAPHY; BONE STRENGTH; CONTROLLED STUDY; FRACTURE HEALING; HISTOLOGY; MALE; MANDIBLE FRACTURE; MORPHOMETRICS; NONHUMAN; POSTOPERATIVE PERIOD; RABBIT; RADIODENSITOMETRY; SINGLE DRUG DOSE;

ANIMALS; BIOMECHANICS; BONE DENSITY CONSERVATION AGENTS; DIPHOSPHONATES; FRACTURE HEALING; IMIDAZOLES; MALE; MANDIBULAR FRACTURES; RABBITS;

EID: 79956343390     PISSN: 02782391     EISSN: 15315053     Source Type: Journal    
DOI: 10.1016/j.joms.2010.07.063     Document Type: Article

References (63)

1. Amanat N, Brown R, Bilston LE, et al: A single systemic dose of pamidronate improves bone mineral content and accelerates restoration of strength in a rat model of fracture repair. J Orthop Res 23:1029, 2005
2. Nakamura T, Hara Y, Tagawa M, et al: Recombinant human basic fibroblast growth factor accelerates fracture healing by enhancing callus remodeling in experimental dog tibial fracture. J Bone Miner Res 13:942, 1998
3. Al Ruhaimi KA: Effect of adding resorbable calcium sulfate to grafting materials on early bone regeneration in osseous defects in rabbits. Int J Oral Maxillofac Implants 15:859, 2000
4. Bertone AL, Pittman DD, Bouxsein ML, et al: Adenoviral-mediated transfer of human BMP-6 gene accelerates healing in a rabbit ulnar osteotomy model. J Orthop Res 22:1261, 2004
5. Doetsch AM, Faber J, Lynnerup N, et al: The effect of calcium and vitamin D3 supplementation on the healing of the proximal humerus fracture: A randomized placebo-controlled study. Calcif Tissue Int 75:183, 2004
6. Andreassen TT, Ejersted C, Oxlund H: Intermittent parathyroid hormone (1 to 34) treatment increases callus formation and mechanical strength of healing rat fractures. J Bone Miner Res 14:960, 1999
7. Cao Y, Mori S, Mashiba T, et al: Raloxifene, estrogen, and alendronate affect the processes of fracture repair differently in ovariectomized rats. J Bone Miner Res 17:2237, 2002
8. Bilston LE, Little DG, Smith NC, et al: Zoledronic acid improves the mechanical properties of normal and healing bone. Clin Biomech 17:716, 2002
9. Pampu AA, Dolanmaz D, Tuz HH, et al: Experimental evaluation of the effects of zoledronic acid on regenerate bone formation and osteoporosis in mandibular distraction osteogenesis. J Oral Maxillofac Surg 64:1232, 2006
10. Aaron RK, Ciombor DM, Simon BJ: Treatment of nonunions with electric and electromagnetic fields. Clin Orthop 419:21, 2004
11. Hagiwara T, Bell WH: Effect of electrical stimulation on mandibular distraction osteogenesis. J Craniomaxillofac Surg 28:12, 2000
12. Chen YJ, Kuo YR, Yang KD, et al: Shock wave application enhances pertussis toxin protein-sensitive bone formation of segmental femoral defect in rats. J Bone Miner Res 18:2169, 2003
13. Mofid MM, Inoue N, Atabey A, et al: Callus stimulation in distraction osteogenesis. Plast Reconstr Surg 109:1621, 2002
14. Lin JH: Bisphosphonates: A review of their pharmacokinetic properties. Bone 18:75, 1996
15. Rodan GA, Martin TJ: Therapeutic approaches to bone disease. Science 289:1508, 2000
16. Walsh JP, Ward LC, Stewart GO, et al: A randomized clinical trial comparing oral alendronate and intravenous pamidronate for the treatment of Paget's disease of bone. Bone 34:747, 2004
17. Wellington K, Goa KL: Zoledronic acid: A review of its use in the management of bone metastases and hypercalcaemia of malignancy. Drugs 63:417, 2003
18. Bone HG, Hosking D, Devogelaer JO, et al: Alendronate phase 3 osteoporosis treatment study group: Ten years' experience with alendronate for osteoporosis in postmenopausal women. N Engl J Med 350:1189, 2004
19. Lane JM, Khan SN, O'Connor WJ, et al: Bisphosphonate therapy in fibrous dysplasia. Clin Orthop 382:6, 2001
20. Devogelaer JP: New uses of bisphosphonates: Osteogenesis imperfecta. Curr Opin Pharmacol 2:748, 2002
21. Lehmann HJ, Mouritzen U, Christgau S, et al: Effect of bisphosphonates on cartilage turnover assessed with a newly developed assay for collagen type 2 degradation products. Ann Rheum Dis 61:530, 2002
22. Maksymowych WP: Bisphosphonates for arthritis: A confusing rationale. J Rheumatol 30:430, 2003
23. Black DM, Delmas PD, Eastell R, et al: Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis. N Engl J Med 356:1809, 2007
24. Fleisch H: Bisphosphonates: Mechanism of action. Endocr Rev 19:80, 1998
25. Erdogan O, Esen E, Ustun Y, et al: Effects of low-intensity pulsed ultrasound on healing of mandibular fractures: An experimental study in rabbits. J Oral Maxillofac Surg 64:180, 2006
26. Elovic RP, Hipp JA, Hayes WC: A method for measuring the structural properties of the rat mandible. Arch Oral Biol 39:1029, 1994
27. Perry AC, Prpa B, Rouse MS, et al: Levofloxacin and trovafloxacin inhibition of experimental fracture-healing. Clin Orthop Relat Res 414:95, 2003
28. Parfitt AM, Drezner MK, Glorieux FH, et al: Bone histomorphometry: Standardization of nomenclature, symbols, and units: Report of the ASBMR Histomorphometry Nomenclature Committee. J Bone Miner Res 2:595, 1987
29. Dimitroulis G: Management of fractured mandibles without the use of intermaxillary wire fixation. J Oral Maxillofac Surg 60:1435, 2002
30. Schmidt BL, Kearns G, Gordon N, et al: A financial analysis of maxillomandibular fixation versus rigid internal fixation for treatment of mandibular fractures. J Oral Maxillofac Surg 58:1206, 2000
31. Tsiridis E, Gamie Z, Conaghan PG, et al: Biological options to enhance periprosthetic bone mass. Injury 38:704, 2007
32. Bhandari M, Bajammal S, Guyatt GH, et al: Effect of bisphosphonates on periprosthetic bone mineral density after total joint arthroplasty: A meta-analysis. J Bone Joint Surg 87:293, 2005
33. Bransford R, Goergens E, Briody J, et al: Effect of zoledronic acid in a L6-L7 rabbit spine model. Eur Spine J 16:557, 2007
34. Rogers MJ, Frith JC, Luckman SP, et al: Molecular mechanisms of action of bisphosphonates. Bone 24:73, 1999
35. van Beek E, Lowik C, van der Pluijm G, et al: The role of geranylgeranylation in bone resorption and its suppression by bisphosphonates in fetal bone explants in vitro: A clue to the mechanism action of nitrogen-containing bisphosphonates. J Bone Miner Res 14:722, 1999
36. Im GI, Qureshi SA, Kenney J, et al: Osteoblast proliferation and maturation by bisphosphonates. Biomaterials 25:4105, 2004
37. Sato M, Grasser W, Endo N, et al: Bisphosphonate action: Alendronate localization in rat bone and effects on osteoclasts ultrastructure. J Clin Invest 88:2095, 1991
38. Hughes DE, Wright KR, Uy HL, et al: Bisphosphonates promote apoptosis in murine osteoclasts in vitro and in vivo. J Bone Miner Res 10:1478, 1995
39. Fisher JE, Rogers MJ, Halasy JM, et al: Alendronate mechanism of action: Geranylgeraniol, an intermediate in the mevalonate pathway, prevents inhibition of osteoclasts formation, bone resorption, and kinase activation in vitro. Proc Natl Acad Sci USA 96:133, 1999
40. Luckman SP, Hughes DE, Coxon FP, et al: Nitrogen-containing bisphosphonates inhibit the mevalonate pathway and prevent post-translational prenylation of GTP-binding proteins, including ras. J Bone Miner Res 13:581, 1998
41. Coxon FP, Thompson K, Rogers MJ: Recent advances in understanding the mechanism of action of bisphosphonates. Curr Opin Pharmacol 6:307, 2006
42. von Knoch F, Jaquiery C, Kowalsky M, et al: Effects of bisphosphonates on proliferation and osteoblast differentiation of human bone marrow stromal cells. Biomaterials 26:6941, 2005
43. Giuliani N, Pedrazzoni M, Negri G, et al: Bisphosphonates stimulate formation of osteoblast precursors and mineralized nodules in murine and human bone marrow cultures in vitro and promote early osteoblastogenesis in young and aged mice in vivo. Bone 22:455, 1998
44. Mathov I, Plotkin LI, Sgarlata CL, et al: Extracellular signal-regulated kinases and calcium channels are involved in the proliferative effect of bisphosphonates on osteoblastic cells in vitro. J Bone Miner Res 16:2050, 2001
45. Naidu A, Dechow PC, Spears R, et al: The effects of bisphosphonates on osteoblasts in vitro. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 106:5, 2008
46. Giuliani N, Girasole G, Pedrazzoni M, et al: Alendronate stimulates b-FGF production and mineralized nodule formation in human osteoblastic cells and osteoblastogenesis in human bone marrow cultures. J Bone Miner Res 10:171, 1995
47. Reid IR, Brown JP, Burckhardt P, et al: Intravenous zoledronic acid in postmenopausal women with low bone mineral density. N Engl J Med 346:653, 2002
48. Viereck V, Emons G, Lauck V, et al: Bisphosphonates pamidronate and zoledronic acid stimulate osteoprotegerin production by primary human osteoblasts. Biochem Biophys Res Commun 291:680, 2002
49. Rodan GA, Fleisch HA: Bisphosphonates: Mechanisms of action. J Clin Invest 97:2692, 1996
50. Villarreal PM, Junquera LM, Martinez A, et al: Study of mandibular fracture repair using quantitative radiodensitometry: A comparison between maxillomandibular and rigid internal fixation. J Oral Maxillofac Surg 58:776, 2000
51. Dempster DW: Bone microarchitecture and strength. Osteoporos Int 14:54, 2003
52. Carbonare LD, Valenti MT, Bertoldo F, et al: Bone microarchitecture evaluated by histomorphometry. Micron 36:609, 2005
53. Laib A, Newitt DC, Lu Y: New model-independent measures of trabecular bone structure applied to in vivo high resolution MR images. Osteoporos Int 13:130, 2002
54. Muller R, Campenhout H, Van Damme B, et al: Morphometric analysis of human bone biopsies: A quantitative structural comparison of histological sections and micro-computed tomography. Bone 23:59, 1998
55. Amanat N, McDonald M, Godfrey C, et al: Optimal timing of a single dose of zoledronic acid to increase strength in rat fracture repair. J Bone Miner Res 22:867, 2007
56. Tengvall P, Skoglund B, Askendal A, et al: Surface immobilized bisphosphonate improves stainless-steel screw fixation in rats. Biomaterials 25:2133, 2004
57. Meraw SJ, Reeve CM: Quantitative analysis of peripheral periimplant bone and influence of alendronate sodium on early bone regeneration. J Periodontol 70:1228, 1999
58. Yoshinari M, Oda Y, Inoue T, et al: Bone response to calcium phosphate-coated and bisphosphonate-immobilized titanium implants. Biomaterials 23:2879, 2002
59. Yildiz A, Esen E, Kurkcu M, et al: Effect of zoledronic acid on osseointegration of titanium implants: An experimental study in an ovariectomized rabbit model. J Oral Maxillofac Surg 68:515, 2010
60. Marx RE, Sawatari Y, Fortin M, et al: Bisphosphonate-induced exposed bone (osteonecrosis/osteopetrosis) of the jaws: Risk factors, recognition, prevention, and treatment. J Oral Maxillofac Surg 63:1567, 2005
61. Body JJ, Diel I, Bell R: Profiling the safety of and tolerability of bisphosphonates. Semin Oncol 31:73, 2004
62. Marx RE: Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: A growing epidemic. J Oral Maxillofac Surg 61:1115, 2003
63. Chen T, Berenson J, Vescio R, et al: Pharmacokinetics and pharmacodynamics of zoledronic acid in cancer patients with bone metastases. J Clin Pharmacol 42:1228, 2002